Abstract
Ischemia Reversal Program (IRP) is a Panchakarma(five internal bio-cleansing therapies) and allied therapeutic combo. There is paucity of data regarding effect of IRP in patients of ischemic heart disease in the form of myocardial infarction. Here three cases of IHD with history of MI are reported who were treated with IRP. 3 patients of 60,60 and 49 year came to Madhavbaug clinic with chief complaints ranging from dyspnea on exertion NYHA grade II, nocturia, pedal edema for 1 month. Case 1 had history of myocardial infarction 1.5 years back, while case2 had history of cigarette smoking, regular alcohol intake and myocardial infarction 2 months back and was a known case of diabetes mellitus for 20 years. Case 3 was a known case of hypertension. Their stress test revealed inferolateral ischemia at 3 Mets, inferolateral ischemia at 3.4 Mets and inferior ischemia at 4.6 Mets, respectively. Echocardiography revealed changes ranging from diastolic dysfunction, left ventricular wall motion abnormalities to reduced left ventricular ejection fraction. In order to assess the IRP’s efficacy in IHD, it was found that it improved VO2max, DBP, and SBP (with strong statistical significance) from the start of the trial to the end of the follow-up period. SBP has been one of the prognostic indicators for IHD patients. SBP reduction is linked to a prognostic factor in IHD because it decreases ventricular afterload and enhances endothelial function. Most notably, we discovered that after 90 days of treatment, IRP significantly reduced patients’ reliance on typical allopathic medications. 3 cases of IHD which were successfully treated with IRP therapy were reported in the current research work. IRP reduced systolic and diastolic blood pressure, heart rate which are important prognostic parameters in these patients. The positive effects of IRP therapy were seen in echocardiographic and ECG findings as well.
Locate a Centre
